Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Analysis of amputation free and overall survival by treatment received

Journal of Vascular Surgery

Volumn 51, Issue 5 SUPPL., 2010, Pages 18S-31S

  Bradbury, Andrew W ^a   Adam, Donald J ^a   Bell, Jocelyn ^a   Forbes, John F ^b   Fowkes, F Gerry R ^b   Gillespie, Ian ^b   Ruckley, Charles Vaughan ^b   Raab, Gillian M ^c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c EDINBURGH NAPIER UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANASTOMOSIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMORAL ARTERY; HUMAN; INTERMETHOD COMPARISON; LEG AMPUTATION; LEG ARTERY; LEG ISCHEMIA; LEG REVASCULARIZATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POPLITEAL ARTERY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SAPHENOUS VEIN; SURVIVAL TIME; TREATMENT FAILURE; VEIN GRAFT; VEIN PROSTHESIS;

EID: 77951533705     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2010.01.074     Document Type: Article

References (49)

1. Norgren L., Hiatt W.R., Dormandy J.A., Nehler M.R., Harris K.A., Fowkes F.G., and TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg 33 suppl 1 (2007) S1-S75
2. Adam D.J., Beard J.D., Cleveland T., Bell J., Bradbury A.W., Forbes J.F., et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 366 (2005) 1925-1934
3. Bradbury A.W., Adam D.J., Bell J., Forbes J.F., Fowkes F.G.R., Gillespie I., et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy. J Vasc Surg 51 Suppl 10 (2010) 5S-17S
4. Forbes J.F., Adam D.J., Bell J., Fowkes F.G.R., Gillespie I., Raab G.M., et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: health-related quality of life outcomes, resource utilization, and cost-effectiveness analysis. J Vasc Surg 51 Suppl 10 (2010) 43S-51S
5. Bollinger A., Breddin K., Hess H., Heystraten F.M., Kollath J., Konttila A., et al. Semi-quantitative assessment of lower limb atherosclerosis from routine angiographic images. Atherosclerosis 38 (1981) 339-346
6. Bradbury A.W., Adam D.J., Bell J., Forbes J.F., Fowkes F.G.R., Gillespie I., et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: a description of the severity and extent of disease using the Bollinger angiogram scoring method and the TransAtlantic Inter-Society Consensus II classification. J Vasc Surg 51 Suppl 10 (2010) 32S-42S
7. Bradbury A.W., Adam D.J., Bell J., Forbes J.F., Fowkes F.G.R., Gillespie I., et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: a survival prediction model to facilitate clinical decision making. J Vasc Surg 51 Suppl 10 (2010) 52S-68S
8. Faries P., Morrissey N.J., Teodorescu V., Gravereaux E.C., Burks Jr. J.A., Carroccio A., et al. Recent advances in peripheral angioplasty and stenting. Angiology 53 (2002) 617-626
9. Brass E.P., Anthony R., Dormandy J., Hiatt W.R., Jiao J., Nakanishi A., et al. Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia. J Vasc Surg 43 (2006) 752-759
10. Shaw M.B., DeNunzio M., Hinwood D., Nash R., Callum K.G., and Braithwaite B.D. The results of subintimal angioplasty in a district general hospital. Eur J Vasc Endovasc Surg 24 (2002) 524-527
11. Met R., Van Lienden K.P., Koelemay M.J., Bipat S., Legemate D.A., and Reekers J.A. Subintimal angioplasty for peripheral arterial occlusive disease: a systematic review. Cardiovasc Intervent Radiol 31 (2008) 687-697
12. Sandford R.M., Bown M.J., Sayers R.D., London J.N., Naylor A.R., and McCarthy M.J. Is infrainguinal bypass grafting successful following failed angioplasty?. Eur J Vasc Endovasc Surg 34 (2007) 29-34
13. Loftus I.M., Hayes P.D., and Bell P.R. Subintimal angioplasty in lower limb ischaemia. J Cardiovasc Surg 45 (2004) 217-229
14. Ansel G.M., Botti Jr. C.F., and Silver M.J. The use of femoropopliteal stent-grafts for critical limb ischemia. Tech Vasc Intervent Radiol 8 (2005) 140-145
15. Ansel G.M., Silver M.J., Botti Jr. C.F., Rocha-Singh K., Bates M.C., Rosenfield K., et al. Functional and clinical outcomes of nitinol stenting with and without abciximab for complex superficial femoral artery disease: a randomized trial. Catheter Cardiovasc Intervent 67 (2006) 288-297
16. Tang G.L., and Morasch M.D. Role of stents, drug-eluting stents, and stent-grafts in treatment of infrainguinal arterial disease. Semin Vasc Surg 20 (2007) 37-41
17. Zeller T., Tiefenbacher C., Steinkamp H.J., Langhoff R., Wittenberg G., Schluter M., et al. Nitinol stent implantation in TASC A and B superficial femoral artery lesions: the Femoral Artery Conformexx Trial (FACT). J Endovasc Ther 15 (2008) 390-398
18. Zeller T. Current state of endovascular treatment of femoro-popliteal artery disease. Vasc Med 12 (2007) 223-234
19. McCaslin J.E., Hafez H.M., and Stansby G. Lower-limb revascularization and major amputation rates in England. Br J Surg 94 (2007) 835-839
20. Bosiers M., Cagiannos C., Deloose K., Verbist J., and Peeters P. Drug-eluting stents in the management of peripheral arterial disease. Vasc Health Risk Manage 4 (2008) 553-559
21. Schillinger M., Sabeti S., Loewe C., Dick P., Amighi J., Mlekusch W., et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 354 (2006) 1879-1888
22. Saxon R.R., Dake M.D., Volgelzang R.L., Katzen B.T., and Becker G.J. Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease. J Vasc Intervent Radiol 19 (2008) 823-832
23. Kasapis C., Henke P.K., Chetcuti S.J., Koenig G.C., Rectenwald J.E., Krishnamurthy V.N., et al. Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials. Eur Heart J 30 (2009) 44-55
24. Schmehl J., and Tepe G. Current status of bare and drug-eluting stents in infrainguinal peripheral vascular disease. Expert Rev Cardiovas Ther 6 (2008) 531-538
25. Koppensteiner R., Spring S., Amann-Vesti B.R., Meier T., Pfammatter T., Rousson V., et al. Low-molecular-weight heparin for prevention of restenosis after femoropopliteal percutaneous transluminal angioplasty: a randomized controlled trial. J Vasc Surg 44 (2006) 1247-1253
26. Schindler C., Mueller A., Bramlage P., Boecking W., Kirch W., and Schweizer J. Comparison of selective AT1-receptor blockade versus ACE inhibition for restenosis prophylaxis in patients with peripheral occlusive arterial disease after stent angioplasty: a randomized, controlled, proof-of-concept study. Angiology 58 (2008) 710-716
27. Jacobs D.L., Motaganahalli R.L., Cox D.E., Wittgen C.M., and Peterson G.J. True lumen re-entry devices facilitate subintimal angioplasty and stenting of total chronic occlusions: Initial report. J Vasc Surg 43 (2006) 1291-1296
28. Perera G.B., and Lyden S.P. Current trends in lower extremity revascularization. Surg Clin North Am 87 (2007) 1135-1147
29. Rogers J.H., and Laird J.R. Overview of new technologies for lower extremity revascularization. Circulation 116 (2007) 2072-2085
30. Lantis J., Jensen M., Benvenisty A., Mendes D., Gendics C., and Todd G. Outcomes of combined superficial femoral endovascular revascularization and popliteal to distal bypass for patients with tissue loss. Ann Vasc Surg 22 (2008) 366-371
31. Tangelder M.J., Algra A., Lawson J.A., and Eikelboom B.C. Risk factors for occlusion of infrainguinal bypass grafts. Eur J Vasc Endovasc Surg 20 (2000) 118-124
32. Albers M., Battistella V.M., Romiti M., Rodrigues A.A., and Pereira C.A. Meta-analysis of polytetrafluoroethylene bypass grafts to infrapopliteal arteries. J Vasc Surg 37 (2003) 1263-1269
33. Conte M.S., Bandyk D.F., Clowes A.W., Moneta G.L., Seely L., Lorenz T.J., et al., PREVENT III Investigators. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg 43 (2006) 742-751
34. Solakovic E., Totic D., and Solakovic S. Femoro-popliteal bypass above knee with saphenous vein vs synthetic graft. Bos J Basic Med Sci 8 (2008) 367-372
35. Alexander J., Gutierrez C.M., and Katz S. Non-greater saphenous vein grafting for infrageniculate bypass. Am Surg 68 (2002) 611-614
36. Alcocer F., Jordan Jr. W.D., Wirthlin D.J., and Whitley D. Early results of lower extremity infrageniculate revascularization with a new polytetrafluoroethylene graft. Vascular 12 (2004) 318-2
37. Bosiers M., Deloose K., Verbist J., Schroe H., Lauwers G., Lansink W., et al. Heparin-bonded expanded polytetrafluoroethylene vascular graft for femoropopliteal and femorocrural bypass grafting: 1-year results. J Vasc Surg 43 (2006) 313-318
38. Gulkarov I., Malik R., Yakubov R., Gagne P., Muhs B.E., Rockman C., et al. Early results for below-knee bypasses using Distaflo. Vasc Endovasc Surg 42 (2008) 561-566
39. Hamdan A.D., Rayan S.S., Hook S.C., Campbell D.R., Akbari C.M., LoGerfo F.W., et al. Bypasses to tibial vessels using polytetrafluoroethylene as the solo conduit in a predominantly diabetic population. Vasc Endovasc Surg 36 (2002) 59-63
40. Lauterbach S.R., Torres G.A., Andros G., and Oblath R.W. Infragenicular polytetrafluoroethylene bypass with distal vein cuffs for limb salvage: a contemporary series. Arch Surg 140 (2005) 487-493
41. Faries P.L., Arora S., Pomposelli Jr. F.B., Pulling M.C., Smakowski P., Rohan D.I., et al. The use of arm vein in lower-extremity revascularization: results of 520 procedures performed in eight years. J Vasc Surg 31 (2000) 50-59
42. Weinberger J., Rundback J.H., and Ratchford E.V. Regulatory approval of peripheral endovascular revascularization devices in the United States: is the horse still in the barn?. Am J Ther 12 (2005) 186-191
43. Davies A.H., Hawdon A.J., Sydes M.R., Thompson S.G., and VGST participants. Is duplex surveillance of value after leg vein bypass grafting?. Principal results of the Vein Graft Surveillance Randomised Trial (VGST). Circulation 112 (2005) 1985-1991
44. Owens C.D., Ho K.J., and Conte M.S. Lower extremity vein graft failure: a translational approach. Vasc Med 13 (2008) 63-74
45. Nowygrod R., Egorova N., Greco G., Anderson P., Gelijns A., Moskowitz A., et al. Trends, complications, and mortality in peripheral vascular surgery. J Vasc Surg 43 (2006) 205-216
46. Mahmud E., Cavendish J.J., and Salami A. Current treatment of peripheral arterial disease: role of percutaneous interventional therapies. J Am Coll Cardiol 50 (2007) 473-490
47. White C.J., and Gray W.A. Endovascular therapies for peripheral arterial disease: an evidence-based review. Circulation 116 (2007) 2203-2215
48. Lee L.K., and Kent K.C. Infrainguinal occlusive disease: endovascular intervention is the first line therapy. Advance Surg 42 (2008) 193-204
49. Cao P., and De Rango P. Endovascular treatment of peripheral arterial disease: so lld yet so far from evidence!. Eur J Vasc Endovasc Surg 37 (2009) 501-503